News

Weill Cornell Medicine investigators have developed a simple, three-dimensional microenvironment to generate functional sperm-like cells in mice, which led to the birth of live pups. The study represents a significant step toward creating viable male gametes entirely outside the human body.

Weill Cornell Medicine has received a four-year, $1.5 million grant from New York’s Empire State Development to increase resources available through BioVenture eLab, the institution’s hub for biomedical entrepreneurship. 

A form of glioma, a type of brain cancer, tends to progress towards greater malignancy due to an increasing tendency of the glioma cells to transform into immature, stem-cell-like states, according to a study led by investigators at Weill Cornell Medicine, the New York Genome Center, Harvard Medical School and Mass General Brigham.

Dr. Mukesh Kumar has been selected as a Collaborative Research Network (CRN) Discovery Fellow by Aligning Science Across Parkinson’s (ASAP).

The National Institute on Aging of the National Institutes of Health has awarded a five-year grant initially worth $8.37 million for Weill Cornell Medicine researchers to study a new gene therapy for Alzheimer’s disease in people who have a high genetic risk of developing the condition. The research could garner nearly $14 million in total if prescribed milestones are reached for years three through five.

An artificial intelligence system that operates like a collaborative team of medical experts could accelerate clinical trial design, one of the most difficult steps in drug development, according to a new study by Weill Cornell Medicine investigators. 

A protein produced by gut immune cells orchestrates both immune protection against pathogens and immune tolerance of gut bacteria, according to a study led by Weill Cornell Medicine investigators.

An aging Baby Boomer generation and contracting nursing home supply will put unprecedented pressure on long-term nursing home services in the United States. 

Patients with advanced prostate cancer may need periodic imaging scans to catch tumor growth even with stable levels of prostate-specific antigen (PSA), a protein in the blood that doctors routinely monitor for cancer progression, according to an analysis led by researchers at Weill Cornell Medicine and Duke University.

A small subset of T cells, called stem T cells, are responsible for making new T cells and for continuously replenishing them in chronic disease, according to a team of scientists from Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center.

Researchers at Columbia University Irving Medical Center and Weill Cornell Medicine have won a $17.25 million grant from the Aligning Research to Understand Autism initiative to study profound autism, which affects over one quarter of individuals who are on the autism spectrum. 

More than 30 Weill Cornell Medicine faculty and staff were honored June 25 with Excellence in Medical Education Awards at a ceremony held on campus.

Chronic psychological stress can help tumors evade immune attack through a chain of molecular events involving gut bacteria and viruses within those bacteria, according to a study led by Weill Cornell Medicine investigators.

Awards, honors and achievements for the month of June.

Over the last two decades, the Weill Cornell Community Clinic has become a bedrock of care for uninsured New Yorkers while also evolving into a deeply embedded part of medical education at Weill Cornell Medical College. 

A recent paper examines the academic, economic and organizational forces jeopardizing a career as a physician-scientist and proposes a framework with the potential to both remedy and revitalize this unique workforce.

Loss of GATA6—a transcription factor that controls which genes are turned on or off—can reprogram colorectal cancer cells into more primitive, adaptable states that can then spread to the liver and establish new tumors, according to Weill Cornell Medicine and Massachusetts Institute of Technology (MIT) researchers.

A new gene therapy appears to be safe in patients diagnosed with Friedreich ataxia cardiomyopathy, a progressive and fatal inherited cardiac disease, according to a phase 1 clinical trial led by Weill Cornell Medicine researchers. 

Dr. Gunisha Kaur has been appointed to the U.S. Commission on International Religious Freedom, an independent, bipartisan legislative branch agency that globally monitors the universal right to freedom of religion or belief.

As the 2026 academic year wrapped up, 99 Cornell employees celebrated completing their degrees while balancing the demands of full-time work.